<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Vishal John</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
  
  <style>
      
      
        
        
        body {
            font-family: 'Arial', sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f4f4f4;
            color: #333;
        }

        header {
            background-color: #fff;
            padding: 20px;
            box-shadow: 0px 3px 10px rgba(0, 0, 0, 0.1);
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        header h1 {
            margin: 0;
        }

        nav ul {
            list-style-type: none;
            padding: 0;
            display: flex;
            justify-content: space-around;
        }

        nav li {
            display: inline-block;
        }

        nav a {
            text-decoration: none;
            color: #333;
            padding: 5px 10px;
            border-radius: 3px;
            transition: background-color 0.3s;
        }

        nav a:hover {
            background-color: #f8f8f8;
        }

        .container {
            width: 80%;
            margin: auto;
            padding: 50px 0;
        }

        .main-content {
            background-color: #fff;
            padding: 50px;
            box-shadow: 0px 3px 10px rgba(0, 0, 0, 0.1);
        }

        .main-content h2, .main-content p {
            margin: 20px 0;
        }

        footer {
            text-align: center;
            padding: 20px 0;
            background-color: #333;
            color: #fff;
        }

       /* Styles for social media icons */
        footer i {
            color: #ff5733;  /* Change this color as you desire */
        }

        footer a:hover i {
            color: #ff9966;  /* Change this color as you desire */
        }

  .publication-item {
            display: flex;
            justify-content: space-between;
            align-items: center;
            border-bottom: 1px solid #e5e5e5;
            padding: 15px 0;
        }

        .publication-item:last-child {
            border-bottom: none;
        }

        .publication-title {
            flex: 1;
            margin-right: 20px;
        }

        .publication-details {
            color: #888;
            font-size: 14px;
        }
      
    </style>
</head>

<body>

    <header>
        <h1><a href="index.html" style="text-decoration: none; color: inherit;">Vishal John</a></h1>

      <nav>
            <ul>
                <li><a href="index.html">Home</a></li>
                <li><a href="about.html">About Me</a></li>
                 <li><a href="blog.html">Newsletter</a></li>
                <li><a href="publications.html">Publications</a></li>
                <li><a href="contact.html">Contact</a></li>
            </ul>
        </nav>
    </header>

    
      <div class="container">
    <div class="main-content">
    
        
        <!-- Add the image here -->
        <img src="Photo1.jpg" alt="Pipetting" style="width: 50%; display: block; margin: 0 auto 20px;">
            
        <p style="text-align: center;"><strong>Our "young" PI teaching us how to pipette</strong></p>

        
        <h2>Publications</h2>


            <!-- Publication 5 -->
            <div class="publication-item">
                <div class="publication-title">
                    <strong>Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways:</strong>
                </div>
                <div class="publication-description">
                    H3K27M-mutant diffuse midline glioma (DMG) patients have no proven effective therapies... <a href="https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-23-0131/728431/Clinical-efficacy-of-ONC201-in-H3K27M-mutant" target="_blank" class="publication-link">Read Paper</a>
                </div>
            </div>
            
            <!-- Publication 1 -->
            <div class="publication-item">
                <div class="publication-title">
                    <strong>Liquid biopsy in pediatric brain tumors:</strong>
                </div>
                <div class="publication-description">
                    Malignant primary brain tumors are the most common cancer in children aged 0–14 years ... <a href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1114762/full" target="_blank" class="publication-link">Read Paper</a>
                </div>
            </div>

            <!-- Publication 2 -->
            <div class="publication-item">
                <div class="publication-title">
                    <strong>Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy:</strong>
                </div>
                <div class="publication-description">
                    Gliomas are tumors derived from mutations in glial brain cells ... <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.882452/full" target="_blank" class="publication-link">Read Paper</a>
                </div>
            </div>

            <!-- Publication 3 -->
            <div class="publication-item">
                <div class="publication-title">
                    <strong>Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma:</strong>
                </div>
                <div class="publication-description">
                    To our knowledge, we report the first demonstrated feasibility for serial CSF collection ... <a href="https://academic.oup.com/neuro-oncology/article/24/8/1366/6523277?login=false" target="_blank" class="publication-link">Read Paper</a>
                </div>
            </div>

            <!-- Publication 4 -->
            <div class="publication-item">
                <div class="publication-title">
                    <strong>Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing:</strong>
                </div>
                <div class="publication-description">
                    Molecular markers are essential for cancer diagnosis ... <a href="https://www.nature.com/articles/s42003-022-03657-6" target="_blank" class="publication-link">Read Paper</a>
                </div>
            </div>
            
            <!-- ... Continue in the same format for the rest of the publications ... -->

        </div>
    </div>

    
   <footer>
      <a href="https://www.linkedin.com/in/vishaljjohn/" target="_blank"> <i class="fab fa-linkedin fa-2x"> </i>
       <a href="https://github.com/vishaljjohn" target="_blank"> <i class="fab fa-github fa-2x"> </i> 
        <a href="https://medium.com/@vishaljjohn" target="_blank"> <i class="fab fa-medium fa-2x"> </i> 
       </a>  <p>© 2023 Vishal John. All Rights Reserved.</p>
   
    </footer>

</body>

</html>



